Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate
Work
Year: 2023
Type: article
Abstract: Deamidation, a common post-translational modification, may impact multiple physiochemical properties of a therapeutic protein. MEDI7247, a pyrrolobenzodiazepine (PBD) antibody-drug conjugate (ADC), co... more
Source: Antibodies
Institutions AstraZeneca (United States), AstraZeneca (United Kingdom)
Cites: 32
Cited by: 10
Related to: 10
FWCI: 3.669
Citation percentile (by year/subfield): 81.48
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
APC paid (est): $1,732